The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort
- Lazzaroni, Maria-Grazia
- Marasco, Emiliano
- Campochiaro, Corrado
- DeVries-Bouwstra, Jeska
- Gonzalez-Perez, Montserrat-Ixchel
- Rojas-Serrano, Jorge
- Hachulla, Eric
- Zanatta, Elisabetta
- Barsotti, Simone
- Furini, Federica
- Triantafyllias, Konstantinos
- Abignano, Giuseppina
- Truchetet, Marie-Elise
- De Luca, Giacomo
- De Langhe, Ellen
- Hesselstrand, Roger
- Ingegnoli, Francesca
- Bertoldo, Eugenia
- Smith, Vanessa
- Bellando-Randone, Silvia
- Poormoghim, Hadi
- Colombo, Enrico
- Ceribelli, Angela
- Furloni, Alessio
- Zingarelli, Stefania
- Cavazzana, Ilaria
- Franceschini, Franco
- Del Galdo, Francesco
- Denton, Christopher P
- Cavagna, Lorenzo
- Distler, Oliver
- Allanore, Yannick
- Airò, Paolo
Publication date
January 2021
DOIAbstract
To evaluate clinical associations of anti-PM/Scl antibodies in patients with SSc in a multicentre international cohort, with particular focus on unresolved issues, including scleroderma renal crisis (RC), malignancies, and functional outcome of interstitial lung disease (ILD)
Add to ORKG